Krista Meyer

Title: Innovations by Krista Meyer in Cancer Treatment

Introduction

Krista Meyer is an accomplished inventor based in Steamboat Springs, Colorado. She has made significant contributions to the field of cancer treatment, particularly in the development of predictive tests for patient responses to various therapies. With a total of five patents to her name, her work is paving the way for more personalized and effective cancer treatments.

Latest Patents

Krista Meyer's latest patents include groundbreaking methods for predicting patient benefit from antibody drugs and interleukin-2 (IL2) therapy. One of her notable inventions is a predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein. This method utilizes mass spectrometry data from blood samples to predict how melanoma patients will respond to immune checkpoint inhibitors. By analyzing integrated intensity values from mass-spectral features, the classifier can generate a class label indicating whether a patient is likely to benefit from the treatment.

Another significant patent focuses on predicting whether melanoma patients will benefit from high-dose IL2 therapy. This method also employs mass spectrometry data and a computer classifier to analyze blood samples from patients. The classifiers developed from different patient cohorts can be used in combination to guide treatment decisions effectively.

Career Highlights

Krista Meyer is currently employed at Biodesix, Inc., where she continues to innovate in the field of cancer diagnostics and treatment. Her work is instrumental in advancing the understanding of how different patients respond to therapies, ultimately leading to improved outcomes.

Collaborations

Some of her notable coworkers include Joanna Röder and Julia Grigorieva, who contribute to the collaborative efforts in research and development at Biodesix, Inc.

Conclusion

Krista Meyer is a pioneering inventor whose work in predictive testing for cancer therapies is making a significant impact in the medical field. Her innovative approaches are helping to tailor treatments to individual patient needs, thereby enhancing the effectiveness of cancer care.